Related Experiment Videos
A new method for determining anti-B cell antibodies and their specificity using flow cytometry
A J Berteli1, V Daniel, P Terness
1Department of Transplantation Immunology, University of Heidelberg, Germany.
Journal of Immunological Methods
|August 26, 1993
Summary
A novel flow cytometry method enhances B cell crossmatch sensitivity and specificity. This technique aids in identifying anti-B cell and anti-HLA class II antibody specificities for improved transplant compatibility.
Area of Science:
- Immunology
- Transplantation Science
- Flow Cytometry
Background:
- Accurate B cell crossmatching is crucial for successful organ transplantation.
- Existing methods may lack sufficient sensitivity or specificity in detecting pre-formed antibodies.
- Distinguishing specificities of anti-HLA class II antibodies remains a challenge.
Purpose of the Study:
- To introduce a novel, highly sensitive, and specific flow cytometric B cell crossmatch method.
- To establish a technique for determining the specificity of anti-B cell antibodies.
- To explore the potential for differentiating anti-HLA class II antibody specificities (DR, DQ, DP).
Main Methods:
- Developed a flow cytometric assay utilizing unconjugated polyvalent anti-human immunoglobulin antibody.
- Coated B cell surface immunoglobulins to enhance detection.
- Employed a binding inhibition test with anti-HLA class II specific monoclonal antibodies.
Main Results:
- The new method demonstrates improved sensitivity and specificity in B cell crossmatching.
- Successfully determined the specificity of anti-B cell antibodies.
- Showed potential for differentiating anti-HLA class II specificities (DR, DQ, DP).
Conclusions:
- This enhanced flow cytometric B cell crossmatch method offers a significant advancement in transplant immunology.
- The technique provides valuable insights into antibody specificities, aiding in pre-transplant risk assessment.
- Further application in clinical settings may improve patient outcomes by refining antibody screening and compatibility testing.